
|Articles|January 22, 2016
Myeloma, PsA Drug Approvals Highlight Week in Specialty Pharmacy News
Author(s)Davy James, Managing Editor
Top stories of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/myeloma-psa-drug-approvals-highlight-week-in-speci" target="_blank">View the story "Myeloma, PsA Drug Approvals Highlight Week in Specialty Pharmacy News" on Storify</a>]
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Paradigm Shift in Lipid Management: Highlights from the NLA 2026 Scientific Sessions Opening Session
2
ATTR-CM Red Flags, Treatment Evidence, and the Pharmacist's Role in Care
3
Anticoagulation in AFib: Risk Stratification, Therapy Selection, and Factor XI Inhibitors
4
FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant Treatment of High-Risk Clear Cell RCC
5


































































































































